Relmada Therapeutics, Inc. (RLMD)

NASDAQ: RLMD · Real-Time Price · USD

7.48

+0.48 (6.86%)

At close: Apr 17, 2026, 4:00 PM EDT

7.50

+0.02 (0.27%)

After-hours: Apr 17, 2026, 5:30 PM EDT

Relmada Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.5	3.86	4.09	5.4	44.44
Short-Term Investments	89.51	41.05	92.23	142.93	167.47
Cash & Short-Term Investments	93.01	44.91	96.32	148.32	211.91
Cash Growth	107.10%	-53.38%	-35.06%	-30.01%	80.98%
Other Receivables	-	-	-	0.51	0.09
Total Trade Receivables	-	-	-	0.51	0.09
Other Current Assets	0.98	0.89	1.19	4.04	11.3
Total Current Assets	93.98	45.8	97.51	152.87	223.3
Other Long-Term Assets	0.02	0.02	0.04	0.03	0.03
Total Assets	94	45.82	97.55	152.91	223.33
Accounts Payable	1.57	4.13	3.51	5.26	11.19
Accrued Expenses	4.86	6.16	8.69	7.21	3.87
Total Current Liabilities	6.43	10.29	12.19	12.47	15.06
Other Long-Term Liabilities	1.06	0	-	-	-
Total Long-Term Liabilities	1.06	0	-	-	-
Total Liabilities	7.49	10.3	12.19	12.47	15.06
Common Stock	0.07	0.03	0.03	0.03	0.03
Additional Paid-in Capital	784.71	676.37	646.23	602.52	513.3
Retained Earnings	-	-	-560.9	-462.11	-305.07
Shareholders' Equity	86.51	35.52	85.36	140.44	208.27
Total Liabilities & Equity	94	45.82	97.55	152.91	223.33
Net Cash (Debt)	93.01	44.91	96.32	148.32	211.91
Net Cash Growth	107.10%	-53.38%	-35.06%	-30.01%	80.98%
Net Cash Per Share	2.36	1.49	3.20	5.01	12.07
Book Value	86.51	35.52	85.36	140.44	208.27
Book Value Per Share	2.19	1.18	2.84	4.74	11.87
Tangible Book Value	86.51	35.52	85.36	140.44	208.27
Tangible Book Value Per Share	2.19	1.18	2.84	4.74	11.87

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q